Aydiner, A. Et Al. 2013. Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.5 , 3255-3261.

Aydiner, A., Yildiz, İ., & Seyidova, A., (2013). Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.5, 3255-3261.

Aydiner, Adnan, İBRAHİM YILDIZ, And Avesta Seyidova. "Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status," ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.5, 3255-3261, 2013

Aydiner, Adnan Et Al. "Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.5, pp.3255-3261, 2013

Aydiner, A. Yildiz, İ. And Seyidova, A. (2013) . "Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status." ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , vol.14, no.5, pp.3255-3261.

@article{article, author={Adnan Aydiner Et Al. }, title={Clinical Outcomes and Prognostic Factors Associated with the Response to Erlotinib in Non-Small-Cell Lung Cancer Patients with Unknown EGFR Mutational Status}, journal={ASIAN PACIFIC JOURNAL OF CANCER PREVENTION}, year=2013, pages={3255-3261} }